SEC 13F Intelligence

Gagnon Advisors, LLC / HQ8F

Gagnon Advisors, LLC’s Apollo Endosurgery Inc Position

Does Gagnon Advisors, LLC own Apollo Endosurgery Inc (HQ8F)? Not currently — the last reported position was 1.33M shares worth $13M in Q4 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$13M
Q4 2022
Shares
1.33M
% of Portfolio
+8.95%
Quarters Held
17
position exited

Position History HQ8F

Reported value by quarter
Q4 ’18: $2MQ4 ’18Q1 ’19: $2MQ2 ’19: $2MQ3 ’19: $2MQ3 ’19Q4 ’19: $1MQ1 ’20: $998,000Q2 ’20: $850,000Q2 ’20Q3 ’20: $2MQ4 ’20: $4MQ1 ’21: $7MQ1 ’21Q2 ’21: $11MQ3 ’21: $12MQ4 ’21: $11MQ4 ’21Q1 ’22: $8MQ2 ’22: $5MQ3 ’22: $7MQ3 ’22Q4 ’22: $13Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 20221.33M$13M+8.95%
Q3 20221.33M$7M+4.74%
Q2 20221.33M$5M+2.94%
Q1 20221.33M$8M+3.71%
Q4 20211.33M$11M+4.45%
Q3 20211.33M$12M+4.78%
Q2 20211.33M$11M+4.09%
Q1 20211.20M$7M+1.40%
Q4 20201.20M$4M+1.84%
Q3 2020919.8K$2M+0.95%
Q2 2020519.8K$850,000+0.61%
Q1 2020519.8K$998,000+0.93%
Q4 2019519.8K$1M+0.83%
Q3 2019519.8K$2M+1.06%
Q2 2019519.8K$2M+0.96%
Q1 2019519.8K$2M+1.11%
Q4 2018519.8K$2M+1.26%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Gagnon Advisors, LLC’s full portfolio or all institutional holders of HQ8F.